Infectivity of West Nile/Dengue Chimeric Viruses for West Nile and Dengue Mosquito Vectors
- 1 March 2005
- journal article
- research article
- Published by Mary Ann Liebert Inc in Vector-Borne and Zoonotic Diseases
- Vol. 5 (1), 1-10
- https://doi.org/10.1089/vbz.2005.5.1
Abstract
West Nile virus (WN), an agent of significant human and veterinary disease, is endemic in the Old World and rapidly spreading throughout the Americas. Vaccines are needed to halt the geographic expansion of this virus and prevent disease where it is established. However, to preclude introduction of a vaccine virus into the environment, a live attenuated WN vaccine should have low potential for transmission by mosquitoes. A chimeric WN vaccine candidate was previously generated by replacing the membrane and envelope structural protein genes of recombinant dengue type 4 virus (rDEN4) with those of WN; a derivative of this virus, WN/DEN4-3'Delta 30, contains a 30-nucleotide deletion in the 3' untranslated region. To assess the potential for transmission by mosquitoes of these vaccine candidates, the ability of each chimeric virus to infect the mosquito midgut, disseminate to the head, and pass into the saliva was compared to that of their wild-type parental WN and DEN4 viruses in three vector species. The WN/DEN4 chimeric viruses were significantly attenuated in both Culex tarsalis, a vector able to transmit WN but not dengue, and in Ae. aegypti, a vector able to transmit dengue but not WN. However, the chimeric viruses were as infectious as either wild-type virus for Ae. albopictus, a vector able to transmit both dengue and WN. These results indicate that chimerization caused a contraction in vector host range rather than universal attenuation for mosquitoes per se. This restriction in potential vectors renders it less likely that WN/DEN4 and WN/DEN4-3'Delta 30 would be transmitted from vaccinees to mosquitoes.Keywords
This publication has 30 references indexed in Scilit:
- Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cellsVaccine, 2003
- A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4Virology, 2003
- Vector Competence of California Mosquitoes for West Nile virusEmerging Infectious Diseases, 2002
- The Molecular Biology of West Nile Virus: A New Invader of the Western HemisphereAnnual Review of Microbiology, 2002
- West Nile virusThe Lancet Infectious Diseases, 2002
- Vector Infection Determinants of Venezuelan Equine Encephalitis Virus Reside within the E2 Envelope GlycoproteinJournal of Virology, 2002
- Experimental Infection of Horses with West Nile virusEmerging Infectious Diseases, 2002
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.The American Journal of Tropical Medicine and Hygiene, 2001
- Molecular basis of bunyavirus per os infection of mosquitoes: role of the middle-sized RNA segment.Proceedings of the National Academy of Sciences, 1982
- Molecular Basis of Bunyavirus Transmission by Mosquitoes: Role of the Middle-Sized RNA SegmentScience, 1981